Equity Profile

BCPC

Balchem Corporation

MaterialsSpecialty Chemicals$5.2B

Apr30Thu

Post-Earnings Recap

ReportedQ1-2026Pre-Market7:00 AM EDT

Balchem Corporation Matches on EPS, Stock Down 6.76%

Metric	Actual	Expected	Surprise
EPS	$1.33	$1.33	+0.00%
Revenue	N/A	$267M	N/A

management commentary, guidance changes, and full analysis available with Pro.

Balchem Corporation Matches on EPS, Stock Down 6.76%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$1.33	$1.33	+0.00%
Revenue	N/A	$267M	N/A

Management Commentary

Tone: Unknown

No transcript is on record, so the analysis is based solely on numerical results.

What It Means

Balchem Corporation reported earnings that matched expectations for EPS, but there was no revenue figure provided. The stock reacted negatively, dropping 6.76%, which may indicate investor concerns about future performance or the lack of revenue guidance. Without additional context from management, it's difficult to assess the company's outlook.

Company Snapshot

Balchem Corporation (BCPC) operates in the specialty chemicals sector, focusing on producing and marketing innovative solutions for various industries, including food, pharmaceuticals, and agriculture. With a market cap of $6 billion, the company plays a crucial role in providing essential materials that enhance product performance and safety.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$1.33

Revenue

Revenue figures provide insight into the company's sales performance and market demand.

$267M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+3.47%

Avg Stock Reaction

+0.12%

Last Quarter Recap

In Q4-2025, Balchem reported an EPS of $1.31, exceeding estimates by 1.95%. However, the stock reacted negatively, declining by 2.11% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Balchem to report solid earnings this quarter, with a consensus EPS of $1.33. Investors will be closely watching for any updates on revenue growth and market conditions.

Bull Case

If Balchem beats earnings expectations, it could signal strong demand for its products and lead to a positive stock reaction, potentially boosting investor confidence.

Bear Case

On the other hand, if the company misses its earnings target, it may raise concerns about market demand and profitability, leading to a decline in stock price.

Key Metrics to Watch

EPS

$1.33

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$267M

Revenue figures provide insight into the company's sales performance and market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Balchem's EPS exceed the consensus estimate of $1.33?

A beat on EPS would indicate stronger profitability and could positively impact investor sentiment.

What are the revenue figures compared to the consensus of $267M?

Revenue performance is critical for assessing market demand and overall business health.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating Balchem's ability to leverage its innovative product lines, which could drive revenue growth beyond expectations.

Supporting Evidence

Balchem has consistently beaten EPS estimates in 75% of the last eight quarters.

The options market is pricing a larger move than historical averages, suggesting potential for a significant surprise.

Key Risk

If revenue significantly exceeds $267M, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on whether Balchem can meet or exceed expectations in a challenging market environment.

Bull Confirmed If

An EPS of $1.35 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $1.30 would confirm the bear case, raising concerns about profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±2.91%

Historical Avg

±3.0%

In line with history

The options market is pricing in a move of nearly 3% around the earnings report, indicating some uncertainty among investors.

Options are pricing ±2.9% while BCPC has averaged ±3.0% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.3%

30d HV

15.9%

Calls (100)P/C Ratio: 0.50Puts (100)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Materials

n=30

Fade rate: 8 of 22 (36%)

This setup has occurred 30 times across Materials in the last 2 years. 14 of 22 (64%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 2.9%, with a raw directional average of -0.4% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Balchem beats expectations, history suggests a positive stock reaction, with an average 1-day move of +1.51%.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further commentary.

Miss

A miss could lead to a decline, with historical data indicating an average 1-day move of +0.73% when expectations are not met.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations.
2Insights into market demand and customer feedback.
3Comments on cost management and operational efficiencies.
4Guidance on future revenue growth and market conditions.
5Any discussion on competitive pressures in the specialty chemicals sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Apr27

VZReported

Verizon Communications Inc.

Congress activity

RecapView

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$1.33

Revenue

Revenue figures provide insight into the company's sales performance and market demand.

$267M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+3.47%

Avg Stock Reaction

+0.12%

Last Quarter Recap

In Q4-2025, Balchem reported an EPS of $1.31, exceeding estimates by 1.95%. However, the stock reacted negatively, declining by 2.11% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Balchem to report solid earnings this quarter, with a consensus EPS of $1.33. Investors will be closely watching for any updates on revenue growth and market conditions.

Bull Case

If Balchem beats earnings expectations, it could signal strong demand for its products and lead to a positive stock reaction, potentially boosting investor confidence.

Bear Case

On the other hand, if the company misses its earnings target, it may raise concerns about market demand and profitability, leading to a decline in stock price.

Key Metrics to Watch

EPS

$1.33

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$267M

Revenue figures provide insight into the company's sales performance and market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Balchem's EPS exceed the consensus estimate of $1.33?

A beat on EPS would indicate stronger profitability and could positively impact investor sentiment.

What are the revenue figures compared to the consensus of $267M?

Revenue performance is critical for assessing market demand and overall business health.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating Balchem's ability to leverage its innovative product lines, which could drive revenue growth beyond expectations.

Supporting Evidence

Balchem has consistently beaten EPS estimates in 75% of the last eight quarters.

The options market is pricing a larger move than historical averages, suggesting potential for a significant surprise.

Key Risk

If revenue significantly exceeds $267M, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on whether Balchem can meet or exceed expectations in a challenging market environment.

Bull Confirmed If

An EPS of $1.35 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $1.30 would confirm the bear case, raising concerns about profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±2.91%

Historical Avg

±3.0%

In line with history

The options market is pricing in a move of nearly 3% around the earnings report, indicating some uncertainty among investors.

Options are pricing ±2.9% while BCPC has averaged ±3.0% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.3%

30d HV

15.9%

Calls (100)P/C Ratio: 0.50Puts (100)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Materials

n=30

Fade rate: 8 of 22 (36%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Balchem beats expectations, history suggests a positive stock reaction, with an average 1-day move of +1.51%.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further commentary.

Miss

A miss could lead to a decline, with historical data indicating an average 1-day move of +0.73% when expectations are not met.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations.
2Insights into market demand and customer feedback.
3Comments on cost management and operational efficiencies.
4Guidance on future revenue growth and market conditions.
5Any discussion on competitive pressures in the specialty chemicals sector.